Loading fund information
Price chart (1D to 10Y)
Licensed market data — shown to members, not published to the open web.
The fund’s disclosed portfolio, not an index membership list. Showing the largest 25 of 252 positions. The ten largest identified positions carry 54.3% of the portfolio.
| # | Holding | Sector | Country | Weight | Filed value |
|---|---|---|---|---|---|
| 1 | BlackRock Funds III | — | United States | 11.66% | $1.05B |
| 2 | Vertex Pharmaceuticals, Inc. VRTX | Healthcare | United States | 8.08% | $734.31M |
| 3 | Amgen, Inc. AMGN | Healthcare | United States | 7.82% | $711.36M |
| 4 | Gilead Sciences, Inc. GILD | Healthcare | United States | 6.84% | $621.78M |
| 5 | Regeneron Pharmaceuticals, Inc. REGN | Healthcare | United States | 4.90% | $445.86M |
| 6 | Argenx SE ARGX | Healthcare | Netherlands | 3.75% | $341.58M |
| 7 |
Source: SEC filings. Information and analytics, not investment advice.
| Healthcare |
| United States |
| 3.12% |
| $283.62M |
| 8 | Natera, Inc. NTRA | Healthcare | United States | 2.89% | $262.67M |
| 9 | Revolution Medicines, Inc. RVMD | Healthcare | United States | 2.78% | $252.66M |
| 10 | Biogen, Inc. BIIB | Healthcare | United States | 2.46% | $224.08M |
| 11 | Illumina, Inc. ILMN | Healthcare | United States | 2.06% | $188.02M |
| 12 | Moderna, Inc. MRNA | Healthcare | United States | 1.98% | $180.30M |
| 13 | Insmed, Inc. INSM | Healthcare | United States | 1.78% | $162.20M |
| 14 | BeOne Medicines Ltd. ONC | Healthcare | Switzerland | 1.76% | $160.77M |
| 15 | Incyte Corp. INCY | Healthcare | United States | 1.74% | $159.00M |
| 16 | United Therapeutics Corp. UTHR | Healthcare | United States | 1.73% | $157.56M |
| 17 | Roivant Sciences Ltd. ROIV | Healthcare | Bermuda | 1.42% | $129.58M |
| 18 | Neurocrine Biosciences, Inc. NBIX | Healthcare | United States | 1.29% | $117.98M |
| 19 | Ascendis Pharma A/S ASND | Healthcare | Denmark | 1.28% | $116.85M |
| 20 | Genmab A/S GMAB | Healthcare | Denmark | 1.11% | $101.66M |
| 21 | Exelixis, Inc. EXEL | Healthcare | United States | 1.03% | $93.91M |
| 22 | Ionis Pharmaceuticals, Inc. IONS | Healthcare | United States | 1.00% | $91.06M |
| 23 | Bridgebio Pharma, Inc. BBIO | Healthcare | United States | 0.98% | $89.23M |
| 24 | Medpace Holdings, Inc. MEDP | Healthcare | United States | 0.95% | $86.34M |
| 25 | Madrigal Pharmaceuticals, Inc. MDGL | Healthcare | United States | 0.90% | $82.54M |